» Articles » PMID: 12919744

The Glycosylation Status of the Murine Hepatitis Coronavirus M Protein Affects the Interferogenic Capacity of the Virus in Vitro and Its Ability to Replicate in the Liver but Not the Brain

Overview
Journal Virology
Specialty Microbiology
Date 2003 Aug 16
PMID 12919744
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

The coronavirus M protein, the most abundant coronaviral envelope component, is invariably glycosylated, which provides the virion with a diffuse, hydrophilic cover on its outer surface. Remarkably, while the group 1 and group 3 coronaviruses all have M proteins with N-linked sugars, the M proteins of the group 2 coronaviruses [e.g., mouse hepatitis virus (MHV)] are O-glycosylated. The conservation of the N- and O-glycosylation motifs suggests that each of these types of carbohydrate modifications is beneficial to their respective virus. Since glycosylation of the M protein is not required for virus assembly, the oligosaccharides are likely to be involved in the virus-host interaction. In order to investigate the role of the M protein glycosylation in the host, two genetically modified MHVs were generated by using targeted RNA recombination. The recombinant viruses carried M proteins that were either N-glycosylated or not glycosylated at all, and these were compared with the parental, O-glycosylated, virus. The M protein glycosylation state did not influence the tissue culture growth characteristics of the recombinant viruses. However, it affected their interferogenic capacity as measured using fixed, virus-infected cells. Viruses containing M proteins with N-linked sugars induced type I interferons to higher levels than viruses carrying M proteins with O-linked sugars. MHV with unglycosylated M proteins appeared to be a poor interferon inducer. In mice, the recombinant viruses differed in their ability to replicate in the liver, but not in the brain, whereas their in vivo interferogenic capacity did not appear to be affected by their glycosylation status. Strikingly, their abilities to replicate in the liver correlated with their in vitro interferogenic capacity. This apparent correlation might be explained by the functioning of lectins, such as the mannose receptor, which are abundantly expressed in the liver but also play a role in the induction of interferon-alpha by dendritic cells.

Citing Articles

Nucleotide and Amino Acid Analyses of Unique Infectious Bronchitis Virus (IBV) Variants from Canadian Poultry Flocks with Drop in Egg Production.

Farooq M, Ali A, Hassan M, Abdul-Careem M Genes (Basel). 2024; 15(11).

PMID: 39596680 PMC: 11593648. DOI: 10.3390/genes15111480.


Deciphering the Genetic Variation: A Comparative Analysis of Parental and Attenuated Strains of the QXL87 Vaccine for Infectious Bronchitis.

Wang M, Bo Z, Zhang C, Guo M, Wu Y, Zhang X Animals (Basel). 2024; 14(12).

PMID: 38929403 PMC: 11200882. DOI: 10.3390/ani14121784.


Coronavirus M Protein Trafficking in Epithelial Cells Utilizes a Myosin Vb Splice Variant and Rab10.

Lapierre L, Roland J, Manning E, Caldwell C, Glenn H, Vidalain P Cells. 2024; 13(2).

PMID: 38247817 PMC: 10814003. DOI: 10.3390/cells13020126.


Vaccines and Therapeutics for COVID-19 - How Can Understanding SARS-CoV-2 Glycosylation Lead to Pharmaceutical Advances?.

Gleinich A, Pepi L, Shajahan A, Heiss C, Azadi P Am Pharm Rev. 2023; 24(4):14-21.

PMID: 38099300 PMC: 10721230.


Dissecting Phenotype from Genotype with Clinical Isolates of SARS-CoV-2 First Wave Variants.

Taylor M, Williams E, Xue Y, Jenjaroenpun P, Wongsurawat T, Smith A Viruses. 2023; 15(3).

PMID: 36992320 PMC: 10059853. DOI: 10.3390/v15030611.


References
1.
Baudoux P, Besnardeau L, Carrat C, Rottier P, Charley B, Laude H . Interferon alpha inducing property of coronavirus particles and pseudoparticles. Adv Exp Med Biol. 1998; 440:377-86. DOI: 10.1007/978-1-4615-5331-1_49. View

2.
de Haan C, Smeets M, Vernooij F, Vennema H, Rottier P . Mapping of the coronavirus membrane protein domains involved in interaction with the spike protein. J Virol. 1999; 73(9):7441-52. PMC: 104271. DOI: 10.1128/JVI.73.9.7441-7452.1999. View

3.
Peng D, Koetzner C, McMahon T, Zhu Y, Masters P . Construction of murine coronavirus mutants containing interspecies chimeric nucleocapsid proteins. J Virol. 1995; 69(9):5475-84. PMC: 189397. DOI: 10.1128/JVI.69.9.5475-5484.1995. View

4.
Stern D, Sefton B . Coronavirus proteins: structure and function of the oligosaccharides of the avian infectious bronchitis virus glycoproteins. J Virol. 1982; 44(3):804-12. PMC: 256337. DOI: 10.1128/JVI.44.3.804-812.1982. View

5.
de Haan C, Kuo L, Masters P, Vennema H, Rottier P . Coronavirus particle assembly: primary structure requirements of the membrane protein. J Virol. 1998; 72(8):6838-50. PMC: 109893. DOI: 10.1128/JVI.72.8.6838-6850.1998. View